Turnkey business - Ophthalmology services with 3 medical optics offices

Short description

Integrated ophthalmology and medical optics platform, with three premium locations and over 20 years of operational history. The business delivers exceptional financial performance, with a premium EBITDA margin of 64% in 2025, supported by an “asset-light” operating model, a stable team, and organic growth of 11–15% annually.

The company is completely debt-free, generates predictable cash flow, and offers immediate regional scaling potential. The transaction includes all operational assets, team, and standardized processes.

Products and Services

The business offers a wide range of ophthalmological medical services, including diagnosis and treatment for various eye conditions, using advanced Optical Coherence Tomography (OCT) technology.

It sells prescription and sunglasses, contact lenses, and various optical accessories, providing a complete solution for customer needs.

Operations

Scalable operational model

• Infrastructure includes state-of-the-art medical equipment and 3 optimized, strategically positioned locations

• Stable and high-performing team: 4 ophthalmologists with strong local reputation and 10 specialists (optometrists, technicians, support staff) with an average tenure of 12–18 years

• Standardized processes, efficient operational flow

• Integrated supply chain from diagnosis to eyewear production, with minimal lead time and reduced costs

• Replicable model in nearby cities with minimal investment.

Tangible and intangible assets

• Modern medical equipment (OCT, autorefractometers, biomicroscopes, etc.)

• Fully equipped lens assembly laboratory

• Full inventory (value: €120,000, included in the price)

• Loyal patient base built over 25 years

• Contracts with premium suppliers

• Local brand with excellent reputation

• Full team with active employment contracts

• Standardized and documented operational processes

Market and development potential

The regional ophthalmology and medical optics market is under-penetrated and rapidly expanding, providing a favorable context for consolidation and accelerated scaling.

The company benefits from recurring demand across multiple counties, above-industry operating margins, and an “asset-light” model that enables rapid concept replication with minimal capex.

Organic growth of 11–15% annually, achieved without marketing investment, highlights immediate revenue multiplication potential through regional expansion and commercial optimization.

Differentiators:

• Rare financial performance
○ Exceptional EBITDA: €913K, margin 64%
○ Sustained organic growth: CAGR 14%
○ EBITDA to cash conversion: >90%
○ Solvency and financial risk: Zero debt, 0% financial risk

• Full vertical integration: ophthalmology, medical optics, and in-house laboratory

• Mature brand with 25 years of history and excellent market reputation

• Standardized operational processes, easy to transfer and replicate

• Under-penetrated market with significant regional expansion potential

Turnover 2025: €1.417M
EBITDA 2025: €913K
Revenue growth 2023–2025: +15%
Profit margin: 64% When advertising a business for sale, the person doing this advertising has the professional obligation to keep the business's and shareholders' information confidential. Therefore, data fields marked N/A can only be disclosed by signing a Non-Disclosure Agreement (NDA).